Enable JavaScript to visit this website.

Results you can see

The EUCRISA clinical trial program included more than 1500 people with mild-to-moderate eczema, ages 2 to 79, with over 1000 people receiving EUCRISA. Of those, the majority were kids ages 2 to 17. In clinical trials, more people using EUCRISA (32%) achieved clear or almost clear skin than people using the non-medicated Emollient-Rich Vehicle (22%) after 28 days. Some saw clear to almost clear skin in about a week.

VIEW PHOTOS IN OUR GALLERY BELOW TO SEE RESULTS FROM CLINICAL TRIALS AND REAL-WORLD PATIENTS

Slider Image Alt
Body description

Body part result

Explore the different images to see how EUCRISA worked over time to treat
mild-to-moderate eczema.
BEFORE: DAY 1
BEFORE: DAY 1
Forearm
Before • Day 1
Before • Day 1
Hand
Before • Day 1
Before • Day 1
Chin
Before • Day 1
Before • DAY 1
Thumb
Wrist
Calendar

STICK WITH YOUR TREATMENT PLAN

Some people using EUCRISA saw results in as little as 8 days, while even more people were clear or almost clear after 28 days. You should continue to use EUCRISA as prescribed by your doctor.

Some patients may experience burning or stinging where EUCRISA is applied. In our clinical trials, 4% of EUCRISA and 1% of vehicle-treated patients experienced this side effect, and application site pain resolved within 1 day for 78% of those patients.

WHAT IS THE MOST IMPORTANT SAFETY INFORMATION I SHOULD KNOW ABOUT EUCRISA?

EUCRISA may cause side effects including allergic reactions at or near the application site. These can be serious and may include hives, itching, swelling, and redness. If you have any of these symptoms, stop using EUCRISA and get medical help right away.

In clinical trials, 4% of EUCRISA patients experienced application site pain, such as burning or stinging, vs 1% of those who used the non-medicated vehicle. A long-term safety trial (48 weeks) showed a 2% incidence of application site pain in those treated with EUCRISA.

Important Safety Information & Indication

IMPORTANT SAFETY INFORMATION

Do not use EUCRISA if you are allergic to crisaborole or any of the ingredients in EUCRISA.

EUCRISA may cause side effects including allergic reactions at or near the application site. These can be serious and may include hives, itching, swelling, and redness. If you have any of these symptoms, stop using EUCRISA and get medical help right away.

The most common side effect of EUCRISA is application site pain, such as burning or stinging.

EUCRISA is for use on skin (topical use) only. Do not use EUCRISA in your eyes, mouth, or vagina.

INDICATION
EUCRISA is a prescription ointment used on the skin (topical) to treat mild-to-moderate eczema (atopic dermatitis) in adults and children 2 years of age and older.

See Full Prescribing Information .